Cellmid $0.056
(0%)
|
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 14 November 2026 at 4:22am | ||||
CELLMID LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (14-Nov) $12,332,152 (1,885th) |
Close (15-Dec) $0.056 |
Volume (15-Dec) 0 |
Shortsold (8-Dec) 13,278 (0.02%) (428th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.024 |
Agreement Signed for Sale of Lyramid Limited
CDY released this announcement to the ASX on 29 April 2021, 11:31. The announcement is marked as price sensitive, and is 3 page(s) in length and 128.53kb in size.
You can view all announcements from CDY and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from CDY | |
|---|---|
| Results of Meeting | 9 December 2021, 13:11 |
| AGM Presentation to Shareholders | 9 December 2021, 11:03 |
| Release of Shares from Voluntary Escrow | 7 December 2021, 18:47 |
| Agreement Signed for Sale of Lyramid Limited | 29 April 2021, 11:31 |
| Appendix 4C and Quarterly Activity Report | 23 April 2021, 9:54 |
| Change of Director's Interest Notice - Eck | 1 April 2021, 15:45 |
| Change of Director's Interest Notice - Cross | 1 April 2021, 15:45 |
If you were already registered, log in here.
If you were already registered, log in here.